Last week, an FDA advisory committee voted to limit the prescribing of the controversial antibiotic, Ketek.

Now we hear that Eli Lilly failed to disclose clinical trial data that showed patients on Zyprexa were over 3 times more likely to suffer from high blood sugar than those taking placebo.

The NY Times has just gotten its hands on internal, confidential documents from Eli Lilly which showed the drug company played down the side effects of its top-selling, anti-psychotic drug, Zyprexa.

This weekend, drug maker Pfizer learned that it would have to stop its clinical study of heart disease drug, Torcetrapib as the drug was shown to cause an increase in death and heart injury.